Cancer drugs routinely thrown out, wasting millions of dollars per year: study
The health-care system is wasting millions of dollars by buying cancer medications that are thrown out because of the way they are packaged by drug makers — in one-size-fits-all vials that hold too much for most patients, a study found. The waste costs as much as $102 million over a three-year period, according to the study published two years ago in the medical journal Cancer.
In the wake of the coronavirus outbreak, investors who bought "pandemic bonds" from the World Bank in 2017 are set to lose hundreds of millions of dollars. One America's Pearson Sharp has more. As President Trump battles to secure our southern borders, the cost of illegal immigration continues to spiral out of control. It's set to cost Americans trillions of dollars. One America's Pearson Sharp explains. Governments and drug giants must begin expensive and risky work on vaccines against the COVID-19 coronavirus, the World Health Organisation says.… CStone Pharmaceuticals CEO Dr. Frank Jiang says a new area of cancer drugs -- immunotherapy -- is creating "very exciting" results for cancer patients.
Immunotherapy drugs use the body's own immune system to fight cancer cells. CStone's clinical trials with immunotherapies result in varied outcomes based on cancer type and patient background. But Jiang is optimistic. He says there's great promise that cancer treatment will go the way of HIV: A cocktail of treatments personalized to the patient.